Literature DB >> 12114099

Doppler echocardiographic evaluation of right ventricular diastolic function in hypertrophic cardiomyopathy.

G K Efthimiadis1, G E Parharidis, H I Karvounis, K D Gemitzis, I H Styliadis, G E Louridas.   

Abstract

AIMS: Left ventricular diastolic function in patients with hypertrophic cardiomyopathy has been adequately studied. In contrast there are few studies concerning right ventricular diastolic function in hypertrophic cardiomyopathy. We studied right ventricular diastolic function in patients with hypertrophic cardiomyopathy using Doppler echocardiography. METHODS AND
RESULTS: We studied 20 patients with hypertrophic cardiomyopathy (mean age 43.6+/-13.8 years) and 20 healthy volunteers (control group, mean age 43+/-13.8 years). We calculated left ventricular and right ventricular diastolic indices using pulsed Doppler echocardiography. Hypertrophic cardiomyopathy patients compared with controls had significantly lower right ventricular-E/A ratio (1.01+/-0.40 vs 1.30+/-0.28, P<0.04), significantly prolonged right ventricular isovolumic relaxation time (170+/-72 vs 32+/-23 ms, P<0.001), and also significantly prolonged right ventricular deceleration time (160+/-58 vs 118+/-35 ms, P<0.01). There was also strong significant correlation between right ventricular deceleration time and left ventricular deceleration time (r=0.78), right ventricular-E/A ratio and left atrial filling fraction (r=-0.55) and between right atrial filling fraction and left atrial filling fraction (r=0.75).
CONCLUSIONS: Right ventricular diastolic function in patients with hypertrophic cardiomyopathy is impaired, reflecting abnormal relaxation. Right ventricular diastolic indices correlate well with those of left ventricle. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12114099     DOI: 10.1053/euje.2001.0105

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  7 in total

1.  Evaluation of right and left ventricular function using pulsed-wave tissue Doppler echocardiography in patients with subclinical hypothyroidism.

Authors:  F Kosar; I Sahin; N Turan; E Topal; Y Aksoy; C Taskapan
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

2.  Comparison of right ventricular contractile abnormalities in hypertrophic cardiomyopathy versus hypertensive heart disease using two dimensional strain imaging: a cross-sectional study.

Authors:  Luis Afonso; Alex Briasoulis; Nitin Mahajan; Ashok Kondur; Fayez Siddiqui; Sabeeh Siddiqui; Issa Alesh; Shaun Cardozo; Anupama Kottam
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-06       Impact factor: 2.357

Review 3.  RV diastolic dysfunction: time to re-evaluate its importance in heart failure.

Authors:  Richard G Axell; Stephen P Hoole; James Hampton-Till; Paul A White
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

Review 4.  Right ventricular diastolic dysfunction and failure: a review.

Authors:  Youn-Hoa Jung; Xianfeng Ren; Giancarlo Suffredini; Jeffery M Dodd-O; Wei Dong Gao
Journal:  Heart Fail Rev       Date:  2021-05-19       Impact factor: 4.654

Review 5.  The clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure.

Authors:  E R Schwarz; R Dashti
Journal:  Cardiovasc J Afr       Date:  2010 Jul-Aug       Impact factor: 1.167

6.  Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension.

Authors:  Rieko Yoshiyuki; Ryuji Fukushima; Ryo Tanaka; Noboru Machida
Journal:  J Vet Med Sci       Date:  2016-06-17       Impact factor: 1.267

7.  Biatrial performance in children with hypertrophic cardiomyopathy: CMR study.

Authors:  Łukasz Mazurkiewicz; Lidia Ziółkowska; Joanna Petryka; Mateusz Śpiewak; Łukasz Małek; Agata Kubik; Magdalena Marczak; Jolanta Misko; Grażyna Brzezińska-Rajszys
Journal:  Eur Radiol       Date:  2018-06-07       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.